obesity drug

Abbott Pulls Weight Loss Drug Meridia from Market

Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.

FDA Panel Votes Against Arena's Diet Drug

Another diet drug, Arena Pharmaceuticals's Iorcaserin, appears to be in danger after a U.S. Food and Drug Administration advisory panel voted to reject it Thursday.